According to Mouwasat Medical Services Company's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 27.0723. At the end of 2022 the company had a P/E ratio of 34.9.
Year | P/E ratio | Change |
---|---|---|
2022 | 34.9 | 16.23% |
2021 | 30.1 | 15.05% |
2020 | 26.1 | 24.74% |
2019 | 21.0 | -6.3% |
2018 | 22.4 | -0.45% |
2017 | 22.5 | -23.05% |
2016 | 29.2 | 0.18% |
2015 | 29.1 | 12.8% |
2014 | 25.8 | 12.6% |
2013 | 22.9 | 48.97% |
2012 | 15.4 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.